According to BlueQuark, the market for Computer Tomography (CT) is expected to witness substantial growth at a CAGR of 5-6% over the forecast period. Increasing patient emphasis on early and effective disease diagnosis and an increase in the ageing population globally are key drivers boosting the demand for Computer Tomography (CT) over the forecast period. However, the high manufacturing costs and high competition among manufacturers are likely to hinder the market’s growth. 

According to the United Nations Department of Economic and Social Affairs (UN DESA), in 2020, an estimated 727 million persons aged 65 years or over worldwide are projected to double by 2050, reaching 1.5 billion persons. In recent years, there has been a remarkable growth in the availability of computed tomography machines across all corners of the globe. More than 70 million CT scans are being done in the United States annually. Computed Tomography has increased drastically over the past two decades due to the increase in the ageing population of countries like Japan, Italy, Finland, Portugal, and other European countries. The increasing use of CT scans has been mainly in two fields: screening adults (CT scan of lungs in smokers, cardiac and whole-body screening) and CT screening in children. According to the World Health Organization, Cardiovascular diseases are the leading cause of global deaths annually, taking an estimated 17.9 million lives per year, out of which more than 75% of deaths occur in low and developing countries.

According to the Union for International Cancer Control estimates, the global cancer burden has increased to 19.3 million cases and 10 million cancer deaths in 2020. The International Agency for Research on Cancer estimates that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die of this disease. During the COVID-19 pandemic, the increased use of  CT scanning of the chest was beneficial in detecting symptomatic patients with suspected COVID-19, where an RT-PCR test was unavailable or the initial test failed but with high clinical suspicion of COVID-19. Although the risk of dying from COVID-19 increases rapidly as a function of age, older people's level of risk varies considerably from country to country. The primary determinant of COVID-19 mortality among persons aged 60 years or older is the extent to which countries have been able to contain or mitigate the epidemic. According to WHO, the rate of population ageing in the Western Pacific Region is expected to be faster than in almost any other region. It is estimated that approximately 23% of the Western Pacific population will be over 65 years of age by 2050. The increase in the ageing population has led to increased health-related issues like cardiovascular diseases, tumours, haemorrhages, etc. This has led to increased demand for CT scans for early detection of the diseases, which is likely to drive the global Computed Tomography market. The increase in the ageing population has led to increased health-related issues like cardiovascular diseases, tumours, haemorrhages, etc. This has led to increased demand for CT scans for early detection of the diseases, which is likely to drive the global Computed Tomography market.

Computed Tomography (CT) is one of the most powerful hospital equipment. The use of CT has been increasing at a very high rate in hospitals, with an annual increase of 10% of patients every year globally. Japan has the highest number of CT scanners per million population due to its ageing population, which is more prone to health risks. Currently, new technologies are being developed in CT scanners which aim to reduce the soft radiations and make it easy for health care professionals to access them. In several developing countries, such as Africa, the Asia Pacific, and Latin America, the hospital infrastructure is still underdeveloped. The hospital industry in India is forecast to increase to USD 132.84 billion by FY22 from USD 61.79 billion in FY17 at a CAGR of 16–17%. Hospitals in Japan are consolidating to improve efficiency and Brazil is seeing acquisitions by both payers and providers. China’s private hospital sector, which is fortified by supportive government policies and private capital investment, represents the trend. The total number of private hospitals in China reached s reached 21,165 in 2020 and constitutes 63.9% of all hospitals. It is estimated that about USD 400 billion of healthcare construction is underway worldwide. This includes cutting-edge hospitals, groundbreaking research campuses, telehealth centres, and small speciality clinics.

The United States is the world's largest economy. The country's GDP has decreased at an annual rate of 5% in the first quarter and 9.5% in the second quarter of 2020 due to the ongoing coronavirus pandemic. The U.S. economy expanded by an annualized 33.1% in Q3 2020. The United States has a profound presence of Computed Tomography machine manufacturers and suppliers in the country. The overall industry is known for the quality and the standards set by the authorities and governing bodies. United States is one of the largest exporters of CT devices, but in 2019, the dip in trade was caused by the non-tariff barriers by other countries like China, EU, and India in the form of cess and high customs duties. In 2020, due to the outbreak of the COVID-19 pandemic, the demand for CT scanners increased in developing countries because of the increase in chest diagnoses for detection of COVID-19. According to the National Brain Tumor Society (NBTS), in 2020, about 0.7 million people in the United States were suffering from a brain tumour, and around 87,000 people are expected to be diagnosed with it. This increased risk of a brain tumour is likely to increase the CT scans for early detection and is expected to increase demand for Computation Tomography devices.​

It is estimated that 30% or more of imaging examinations may be unnecessary, costing approximately USD 30 billion annually in the United States and in a recent study that compared the United States with ten other countries on various metrics, the United States ranked number 1 in the number of CT and MRI scans performed per 1000 individuals and in the United States CT had been the first line of defence to detect COVID-19. A study by the Radiological Society of North America showed that CT scanner's chest diagnosis found 97% of the COVID infections, whereas the swab test showed 48% accuracy. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending grew 4.6% in 2019, reaching USD 3.8 trillion or USD 11,582 per person. As a share of the nation's GDP, health spending accounted for 17.7%. The country is ready to meet the demand for the Computed Tomography (CT) devices. The government has been in talks with the CT manufacturers for a long time to meet the rapid growth in the demand for both present and upcoming requirements.

BlueQuark's Global CT Scanner Market Outlook to 2029 report provides deep insight into the CT Scanner Market's current and future state across various regions. The report examines the market drivers, restraints, emerging market trends, developments, opportunities, and challenges, along with the detailed impact of COVID-19 on market growth.

The study presents the key elements of the industry supply chain and assesses the industry's attractiveness using Porter's Five Forces framework.

This report also offers an extensively researched competitive landscape section with profiles of prominent companies. Further, the study includes deep-dive analyses on each regional market (Asia-Pacific, North America, Europe, South America, and Middle-East and Africa) and presents analysis across market segments.

Want to know more about what's in this report?

Contact us via the form at the top of the page.